Discordant xenoislets from a large animal donor undergo accelerated graft failure rather than hyperacute rejection: Impact of immunosuppression, islet mass, and transplant site on early outcome

Surgery

Volumn 121, Issue 2, 1997, Pages 194-205

  Troppmann, Christoph ^b   Gruessner, Angelika C ^b   Papalois, Basil E ^b   Nakhleh, Raouf E ^b   Gruessner, Rainer W G ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOFLUORESCENCE; INSULIN RESISTANCE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0031055057     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90290-7     Document Type: Article

References (69)

1. Morel P, Goetz FC, Moudry-Munns K, Freier E, Sutherland DER. Long-term glucose control in patients with pancreatic transplants. Ann Intern Med 1991;115:694-9.
2. Gruessner A, Sutherland DER. Pancreas transplant results in the United Network for Organ Sharing (UNOS) United States of America (USA) Registry compared with non-USA data in the International Registry. In: Terasaki PI, Cecka JM, editors. Clinical Transplants 1994. Los Angeles: UCLA Tissue Typing Laboratory, 1995:47-68.
3. Troppmann C, Dunn DL, Najarian JS, Sutherland DER, Gruessner AC, Gruessner RWG. Operative reintervention following early complications after pancreas transplantation. Transplant Proc 1994;26:454.
4. Troppmann C, Gruessner RWG, Dunn DL, Fasola C, Najarian JS, Sutherland DER. Is transplant pancreatectomy after graft failure necessary? Transplant Proc 1994;26:455.
5. International Islet Transplant Registry Newsletter 1995;5:1-28.
6. Libman I, Songer T, LaPorte R. How many people in the U.S. have IDDM? Diabetes Care 1993;16:841-2.
7. Auchincloss H Jr. Xenogeneic transplantation: a review. Transplantation 1988;46:1-20.
8. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991;52:937-47.
9. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970;2:550-3.
10. Korsgren O, Jansson L. Discordant cellular xenografts revascularized in intermediate athymic hosts fail to induce a hyperacute rejection when transplanted to immunocompetent rats. Transplantation 1994;57:1408-11.
11. Hamelmann W, Gray DWR, Cairns TDJ, et al. Immediate destruction of xenogeneic islets in a primate model. Transplantation 1994;58:1109-14.
12. Song Z, Glover L, Gray DWT, Welsh KI, Morris PJ. An in vitro model of hyperacute rejection of xenogeneic islets [abstract 3.7]. Presented at the Fifth International Congress on Pancreas and Islet Transplantation, Miami, Fla., June 19-26, 1995.
13. Anegon I, Charreau B, Miranda V, et al. Analysis of humoral xenoreactivity in the pig islets-to-human combination: adenovirus-mediated gene transfer into pig islets [abstract 238]. Presented at the Third International Congress for Xenotransplantation, Boston, Mass, September 27-October 1, 1995.
14. Hering BJ. Islet xenotransplantation. In: Ricordi C, editor. Pancreatic islet cell transplantation 1892-1992: one century of transplantation for diabetes. Austin, Texas: RG Landes Co, 1992:313-35.
15. Sakai A, Kountz SL. Dissociation of humoral and cellular immune reactions of the rabbit, guinea pig, and dog kidney xenografts in the rat. J Surg Res 1976;21:159-68.
16. Betz JK, Ketchum RJ, Levy MM, et al. Microlymphocytotoxicity assay to assess reactivity of rodent sera to large animal lymphocytes. Transplant Proc 1994;26:3449-50.
17. Brayman KL, Morel P, Field J, et al. A comparison of mice and rats as recipients for canine islet xenografts. Transplant Proc 1992;24:651-2.
18. Morris RE. Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant Rev 1992;6:39-87.
19. Kaufman DB, Morel P, Field MJ, Munn SR, Sutherland DER. Purified canine islet autografts: functional outcome as influenced by islet number and implantation site. Transplantation 1990; 50:385-91.
20. Morel P, Kaufman DB, Platt J, et al. Islet xenotransplantation in a pre-clinical large animal model. Transplant Proc 1991;23: 875-6.
21. Wahoff DC, Sutherland DER, Hower CD, Lloveras JK, Gores PF. Free intraperitoneal islet autografts in pancreatectomized dogs - impact of islet purity and posttransplantation exogenous insulin. Surgery 1994;116:742-50.
22. Xenos ES, Stevens RB, Sutherland DER, et al. The role of nitric oxide in IL-1β-mediated dysfunction of rodent islets of Langerhans: implications for the function of intrahepatic islet grafts. Transplantation 1994;57:1208-12.
23. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37:413-20.
24. Latif ZA, Noel J, Alejandro R. A simple method of staining fresh and cultured islets. Transplantation 1988;45:827-9.
25. Ricordi C, Gray DWR, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990;27:185-95.
26. Moorhouse JA, Grahame GR, Rosen NJ. Relationship between intravenous glucose tolerance and the fasting blood glucose level in healthy and diabetic subjects. J Clin Endocrinol 1964;24:145-59.
27. Leventhal JR, Matas AJ, Sun LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993;56:1-8.
28. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
29. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982;31: 883-9.
30. Jansson L, Korsgren O, Wahlberg J, Andersson A. Pancreatic islet blood flow after syngeneic pancreaticoduodenal transplantation in rats: differences between the blood perfusion of the native and the transplanted gland. Transplantation 1992;53:517-21.
31. Davis DJ, MacAulay MA, MacDonald AS, Estabrooks BL. Islets of Langerhans in dog pancreas: volume fraction and relative distribution of diameters. Transplantation 1988;45:1099-103.
32. Sandrin MS, McKenzie IFC. Gala (1,3) Gal, the major xenoantigen (s) recognised in pigs by human natural antibodies. Immunological Rev 1994;141:169-90.
33. Inverardi L, Pardi R. Humoral and cellular recognition of discordant xenogeneic Langerhans islets. Transplant Proc 1994; 26:1034-6.
34. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994;344:1402-4.
35. Tze WJ, Tai J, Cheung SS. Transplantation of discordant pig islet xenografts in diabetic rats. Diabetes Res Clin Pract 1992;15:197-204.
36. Tze WJ, Tai J, Cheung SSC, Bissada N, Tsang A. A diabetic rabbit model for pig islet xenotransplantation. Transplantation 1993; 56:1348-52.
37. Menger MD, Jaeger S, Walter P, Feifel G, Hammersen F, Messmer K. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 1989;38:199-201.
38. + T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 1990;172:291-302.
39. Bach FH, Robson SC, Ferran C, et al. Xenotransplantation: endothelial cell activation and beyond. Transplant Proc 1995; 27:77-9.
40. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxidty of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986;232:1545-7.
41. Goto K, Nakamura S, Goto F, Yoshinaga M. Generation of an interleukin-I-like lymphocyte-stimulating factor at inflammatory sites: correlation with the infiltration of polymorphonuclear leucocytes. Br J Exp Path 1984;65:521-32.
42. Gray DWR, Hamelmann W, Cairns TDJ, Ozasa T, Welsh KI, Morris PJ. Removal of natural antibody does not prevent rapid destruction of xenogeneic islets in a primate recipient [abstract P82]. Presented at the Fifth International Congress on Pancreas and Islet Transplantation, Miami, Fla., June 19-26, 1995.
43. Kahan BD, Gibbons S, Tejpal N, Stepkowski SM, Choi TC. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 1991;51:232-9.
44. Ochiai T, Gunji Y, Nagata M, Komori A, Asano T, Isono T. Effects of rapamycin in experimental organ allografting. Transplantation 1993;56:15-9.
45. Knight R, Ferraresso M, Serino F, Katz S, Lewis R, Kahan BD. Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model. Transplantation 1993;55:947-9.
46. Yakimets WJ, Lakey JRT, Yatscoff RW, et al. Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Transplantation 1993; 56:1293-8.
47. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Ann Rev Immunol 1983;1:143-73.
48. Gill RG. The role of direct and indirect antigen presentation in the response to islet xenografts. Transplant Proc 1992;24: 642-3.
49. Greco B, Bielory L, Stephany D, et al. Antithymocyte globulin reacts with many normal human cell types. Blood 1983;62:1047-54.
50. Bonnefoy-Bêrard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991; 51:669-73.
51. Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995;59:1194-200.
52. Aebischer P, Lay PE, Gerasimidi-Vazeou A, Hauptfeld V. Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site. Diabetes 1991;40:482-5.
53. Goss JA, Nakafusa Y, Finke EH, Flye MW, Lacy PE. Induction of tolerance to islet xenografts in a concordant rat-to-mouse model. Diabetes 1994;43:16-23.
54. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994;15:32-8.
55. Wahoff DC, Papalois BE, Najarian JS, et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 1995;222:562-79.
56. Jaeger C, Wohrle M, Bretzel RG, Federlin K. Effect of transplantation site and culture pretreatment on islet xenograft survival (rat to mouse) in experimental diabetes without immunosuppression of the host. Acta Diabetol 1994;31:193-7.
57. + macrophage and not a T-lymphocyte. Transplantation 1995;60:594-601.
58. Andersson A, Korsgren O, Jansson L. Revascularization of islets: intraportally transplanted pancreatic islets revascularized from hepatic arterial system. Diabetes 1989;38:192-5.
59. Lukinius A, Jansson L, Korsgren O. Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol 1995;146:429-35.
60. Ishizuka J, Gugliuzza KK, Wassmuth Z, et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation 1993;56:1486-90.
61. Gunnarsson R, Klintmalm G, Lundgren G, et al. Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporine. Transplant Proc 1984;16:709-12.
62. Leahy JL, Bonner-Weir S, Weir GC. β-cell dysfunction induced by chronic hyperglycemia: current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 1992;15:442-55.
63. Rosenberg L, Clas D, Duguid WP. Trophic stimulation of the ductal/islet cell axis: a new approach to the treatment of diabetes. Surgery 1990;108:191-7.
64. Metrakos P, Yuan S, Agapitos D, Rosenberg L. Intercellular communication and maintenance of islet cell mass - implications for islet transplantation. Surgery 1993;114:423-8.
65. Faustman D, Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991;252:1700-2.
66. Hardy MA, Chabot J. Alteration of pancreatic islet immunogenicity using ultraviolet irradiation. In: van Schilfgaarde R, Hardy MA, editors. Transplantation of the endocrine pancreas in diabetes mellitus. Amsterdam: Elsevier, 1988:301-27.
67. Markees TG, De Fazio SR, Gozzo JJ. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow. Transplantation 1992;53:521-7.
68. Warnock GL, Dabbs KD, Cattral MS, Rajotte RV. Improved survival of in vitro cultured canine islet allografts. Transplantation 1994;57:17-22.
69. Mandel TE, Koulmanda M, Cozzi E, et al. Transplantation of normal and DAF-transgenic fetal pig pancreas into cynomolgus monkeys [abstract 455]. Presented at the XVI International Congress of the Transplantation Society, Barcelona, Spain, August 25-30, 1996.